Torrent Pharma Financials
NSE: TORNTPHARM | BSE: 500420
₹4,890.00
As on 26-Aug-2026IST
Market cap
₹1,85,924 Cr
Revenue (TTM)
₹15,723 Cr
P/E Ratio
85.2
P/B Ratio
20.7
Div. Yield
0.8 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
15,723.00
|
13,979.73
|
11,516.09
|
10,727.84
|
9,620.15
|
8,508.04
|
|||||
|
Total Income
|
15,654.00
|
14,071.44
|
11,556.00
|
10,789.81
|
9,683.37
|
8,704.60
|
|||||
|
Total Expenditure
|
10,532.00
|
9,606.56
|
7,811.74
|
7,364.25
|
6,796.18
|
6,076.77
|
|||||
|
EBITDA
|
5,191.00
|
4,373.17
|
3,704.35
|
3,363.59
|
2,823.97
|
2,431.27
|
|||||
|
Depreciation
|
1,511.00
|
1,118.87
|
794.93
|
808.27
|
706.59
|
662.16
|
|||||
|
EBIT
|
3,680.00
|
3,254.30
|
2,909.42
|
2,555.32
|
2,117.38
|
1,769.11
|
|||||
|
Interest
|
634.00
|
385.07
|
252.31
|
353.56
|
333.44
|
255.06
|
|||||
|
Other Income
|
-69.00
|
91.71
|
39.91
|
61.97
|
63.22
|
196.56
|
|||||
|
Exceptional Items
|
-110.00
|
-88.75
|
-24.21
|
88.38
|
--
|
-484.70
|
|||||
|
Profit before Tax
|
2,867.00
|
2,872.19
|
2,672.81
|
2,352.11
|
1,847.16
|
1,225.91
|
|||||
|
Provision for Tax
|
711.00
|
734.01
|
761.56
|
695.73
|
601.93
|
448.73
|
|||||
|
Profit after Tax
|
2,156.00
|
2,138.18
|
1,911.25
|
1,656.38
|
1,245.23
|
777.18
|
|||||
|
Minority Interest
|
25.00
|
25.19
|
--
|
--
|
--
|
--
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
2,181.00
|
2,163.37
|
1,911.25
|
1,656.38
|
1,245.23
|
777.18
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
8,389.00
|
8,388.43
|
7,590.69
|
6,856.15
|
6,198.07
|
5,952.95
|
|||||
|
Minority Interest
|
25.00
|
9,196.40
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
18,384.00
|
17,685.53
|
2,087.71
|
2,224.05
|
2,822.81
|
2,238.15
|
|||||
|
Current Liabilities
|
8,343.00
|
8,343.33
|
4,717.19
|
5,425.25
|
5,447.30
|
4,415.09
|
|||||
|
Total Liabilities
|
44,312.00
|
43,613.69
|
14,395.59
|
14,505.45
|
14,609.91
|
12,906.28
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
33,955.00
|
34,220.60
|
8,773.02
|
8,893.97
|
9,139.00
|
7,311.54
|
|||||
|
Current Assets
|
9,392.00
|
9,391.89
|
5,622.57
|
5,611.48
|
5,313.72
|
5,164.99
|
|||||
|
Total Assets
|
44,312.00
|
43,613.69
|
14,395.59
|
14,505.45
|
14,609.91
|
12,906.28
|
|||||
|
Total Debt*
|
--
|
14,798.24
|
3,026.09
|
3,937.42
|
5,297.30
|
4,018.10
|
|||||
|
Net Current Assets
|
1,049.00
|
1,048.56
|
905.38
|
186.23
|
-133.58
|
749.90
|
|||||
|
Contingent Liabilities
|
--
|
379.25
|
156.12
|
157.44
|
150.83
|
128.74
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
3,022.71
|
2,585.11
|
3,266.08
|
2,368.13
|
1,802.99
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-12,712.41
|
-540.05
|
-167.90
|
-2,415.31
|
-196.63
|
|||||
|
Cash from Financing Activities
|
--
|
10,150.60
|
-2,297.99
|
-2,779.64
|
77.36
|
-1,781.05
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
460.90
|
-252.93
|
318.54
|
30.18
|
-174.69
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
66.87
|
63.92
|
56.47
|
48.94
|
36.79
|
22.96
|
|||||
|
Cash EPS (₹)
|
57.34
|
96.23
|
79.96
|
72.82
|
57.67
|
42.52
|
|||||
|
Adjusted Book Value (₹)
|
235.97
|
247.84
|
224.27
|
202.57
|
183.13
|
175.87
|
|||||
|
Dividend per Share (₹)
|
0.78
|
38.00
|
32.00
|
28.00
|
22.00
|
48.00
|
|||||
|
Cash Flow per Share (₹)
|
--
|
89.31
|
76.38
|
96.50
|
69.97
|
106.53
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
66.11
|
47.67
|
72.39
|
40.17
|
52.29
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
19.27
|
27.32
|
24.28
|
20.32
|
14.35
|
|||||
|
ROE (%)
|
26.88
|
26.76
|
26.46
|
25.38
|
20.50
|
13.18
|
|||||
|
ROA (%)
|
7.27
|
7.37
|
13.23
|
11.43
|
9.20
|
5.92
|
|||||
|
EBIT Margin (%)
|
23.41
|
23.28
|
25.26
|
23.82
|
22.01
|
20.79
|
|||||
|
Net Margin (%)
|
13.77
|
15.20
|
16.54
|
15.35
|
12.86
|
8.93
|
|||||
|
Cash Profit Margin (%)
|
--
|
16.55
|
16.06
|
14.75
|
11.96
|
9.46
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
32.85
|
21.39
|
7.35
|
11.51
|
13.07
|
6.29
|
|||||
|
EBIT Growth (%)
|
20.66
|
11.85
|
13.86
|
20.68
|
19.69
|
-2.92
|
|||||
|
Net Profit Growth (%)
|
12.04
|
11.87
|
15.39
|
33.02
|
60.22
|
-37.92
|
|||||
|
EPS Growth (%)
|
8.94
|
13.19
|
15.39
|
33.02
|
60.23
|
-37.92
|
|||||
|
Book Value Growth (%)
|
--
|
10.51
|
10.71
|
10.62
|
4.12
|
1.98
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
85.25
|
66.03
|
57.28
|
53.15
|
41.79
|
30.45
|
|||||
|
Price / Book Value
|
20.71
|
17.03
|
14.42
|
12.84
|
8.40
|
7.95
|
|||||
|
Dividend Yield (%)
|
0.78
|
0.90
|
0.99
|
1.08
|
1.43
|
1.72
|
|||||
|
EV/EBITDA
|
38.96
|
35.05
|
29.89
|
26.61
|
19.66
|
19.38
|
|||||
|
Close Price (₹)
|
4,620.10
|
4,220.20
|
3,227.95
|
2,600.60
|
1,537.15
|
1,395.98
|
|||||
|
High Price (₹)
|
4,742.90
|
4,482.90
|
3,590.70
|
2,745.55
|
1,750.00
|
1,652.23
|
|||||
|
Low Price (₹)
|
3,287.30
|
3,101.00
|
2,505.30
|
1,523.05
|
1,242.08
|
1,237.75
|
|||||
|
Market Cap (₹ Cr)
|
1,85,923.81
|
1,42,851.87
|
1,09,477.71
|
88,038.02
|
52,033.47
|
47,324.58
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
1.39
|
1.76
|
0.40
|
0.57
|
0.85
|
0.68
|
|||||
|
Short term debt to equity ratio
|
--
|
0.35
|
0.16
|
0.24
|
0.28
|
0.16
|
|||||
|
Current Ratio
|
1.13
|
1.13
|
1.19
|
1.03
|
0.98
|
1.17
|
|||||
|
Quick Ratio
|
0.75
|
0.75
|
0.66
|
0.62
|
0.57
|
0.62
|
|||||
|
Interest Coverage
|
5.52
|
8.46
|
11.59
|
7.65
|
6.54
|
5.81
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
19.28
|
21.68
|
16.21
|
17.19
|
20.21
|
19.19
|
|||||
|
Asset Turnover
|
0.53
|
0.68
|
1.17
|
1.15
|
1.21
|
1.16
|
|||||
|
Receivable days
|
--
|
45.41
|
40.18
|
41.38
|
39.99
|
37.86
|
|||||
|
Inventory Days
|
--
|
52.67
|
52.20
|
49.26
|
52.47
|
61.71
|
|||||
|
Payable days
|
--
|
244.06
|
279.17
|
279.66
|
243.50
|
306.08
|
|||||
|
Cash Conversion Cycle
|
--
|
-145.98
|
-186.79
|
-189.03
|
-151.04
|
-206.50
|